This strongly suggests that a second and cooperative genetic event (e.g. MYCN amplification) is required to achieve NB tumorigenesis, which is in agreement with the incomplete penetrance of ALK mutations in familial cases. The gene discussed is ALK; the disease is neuroblastoma.